JPMorgan Chase & Co. Acquires 67,662 Shares of Revvity Inc. $RVTY

JPMorgan Chase & Co. grew its stake in Revvity Inc. (NYSE:RVTY) by 15.2% during the 3rd quarter, HoldingsChannel reports. The firm owned 511,360 shares of the company’s stock after acquiring an additional 67,662 shares during the quarter. JPMorgan Chase & Co.’s holdings in Revvity were worth $44,821,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. EdgePoint Investment Group Inc. boosted its stake in Revvity by 26.7% in the 2nd quarter. EdgePoint Investment Group Inc. now owns 6,789,660 shares of the company’s stock valued at $656,696,000 after buying an additional 1,428,813 shares in the last quarter. Norges Bank bought a new position in shares of Revvity during the second quarter valued at $124,574,000. Allspring Global Investments Holdings LLC boosted its stake in shares of Revvity by 14,741.7% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 771,470 shares of the company’s stock valued at $70,790,000 after purchasing an additional 766,272 shares in the last quarter. Invesco Ltd. grew its holdings in shares of Revvity by 25.8% in the 2nd quarter. Invesco Ltd. now owns 2,207,202 shares of the company’s stock worth $213,481,000 after purchasing an additional 452,343 shares during the last quarter. Finally, Diamond Hill Capital Management Inc. bought a new stake in shares of Revvity in the 3rd quarter worth about $35,206,000. 86.65% of the stock is owned by institutional investors and hedge funds.

Revvity Stock Up 1.4%

Shares of NYSE RVTY opened at $98.97 on Friday. Revvity Inc. has a 1 year low of $81.36 and a 1 year high of $120.39. The firm’s 50-day moving average is $103.27 and its 200-day moving average is $96.32. The company has a current ratio of 1.68, a quick ratio of 1.40 and a debt-to-equity ratio of 0.36. The firm has a market capitalization of $11.06 billion, a PE ratio of 47.58, a price-to-earnings-growth ratio of 2.07 and a beta of 1.07.

Revvity (NYSE:RVTY) last announced its quarterly earnings data on Monday, February 2nd. The company reported $1.70 earnings per share for the quarter, beating the consensus estimate of $1.55 by $0.15. Revvity had a net margin of 8.45% and a return on equity of 7.92%. The business had revenue of $772.06 million for the quarter, compared to analyst estimates of $759.81 million. During the same period in the prior year, the business posted $1.42 earnings per share. Revvity’s revenue was up 5.9% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.350-5.450 EPS. Equities analysts expect that Revvity Inc. will post 4.94 EPS for the current year.

Revvity Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, May 8th. Stockholders of record on Friday, April 17th will be given a $0.07 dividend. This represents a $0.28 annualized dividend and a dividend yield of 0.3%. The ex-dividend date is Friday, April 17th. Revvity’s dividend payout ratio (DPR) is currently 13.46%.

Analyst Ratings Changes

RVTY has been the subject of a number of research analyst reports. Bank of America cut shares of Revvity from a “buy” rating to a “neutral” rating and set a $110.00 target price for the company. in a research note on Monday, December 15th. Jefferies Financial Group lifted their price objective on Revvity from $100.00 to $105.00 and gave the company a “hold” rating in a research report on Monday, February 2nd. Weiss Ratings reissued a “sell (d)” rating on shares of Revvity in a research note on Monday, December 29th. Robert W. Baird set a $129.00 price target on Revvity in a report on Tuesday, February 3rd. Finally, Wells Fargo & Company upped their price target on shares of Revvity from $107.00 to $110.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 3rd. Five research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $113.67.

Key Headlines Impacting Revvity

Here are the key news stories impacting Revvity this week:

• Positive Sentiment: Zacks Research raised Revvity’s near-term and FY2026 estimates (Q2 2026 to $1.31, Q3 2026 to $1.34 and FY2026 to $5.36), reflecting stronger-than-expected momentum and aligning with company guidance; higher FY2026 estimates support revenue/earnings beat narratives. MarketBeat: Revvity estimates
• Positive Sentiment: Investors are also responding to coverage of Revvity’s strong Q4 beat and upbeat 2026 outlook — the company reported quarterly EPS and revenue above consensus and provided FY2026 guidance that analysts view as constructive for near-term growth. How Investors May Respond To Revvity Strong Q4 Beat
• Neutral Sentiment: Third‑party comparisons and sector context (e.g., Progyny vs. Revvity) are circulating but are unlikely to materially move the stock absent new company-specific guidance or results. Financial Comparison: Progyny vs. Revvity
• Negative Sentiment: Zacks trimmed several 2027 estimates (Q1 2026 cut to $1.03, Q2/Q3 2027 cuts and FY2027 reduced to $5.90 from $5.97), which temper longer‑term growth expectations and could cap multiple expansion if analysts continue to lower longer-dated forecasts. MarketBeat: Revvity estimates

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.